Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC 3000 Tel: +61 3 9692 7222 Neurizon Completes Initial Drawdown Under Non-Dilutive R&D Financing Facility Highlights: · First drawdown of ~$8.3m under...
Neurizon Completes Initial Drawdown under R&D Facility
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- Neurizon Enters Strategic R&D Financing Facility
- Appendix 4C & Quarterly Update
- Melbourne investor briefing presentation
- HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
- HEALEY Enrolment Complete - Topline Accelerated to Q2 CY27
Later from Neurizon Therapeutics
- Elanco representative appointed as Neurizon Board Observer
- Notification regarding unquoted securities - NUZ
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and 2026 Annual Report
- Application for quotation of securities - NUZ
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics